AI-generated summary
This review examines the state of photobiomodulation (low-level laser therapy) for cancer treatment side effects. The authors report a large body of evidence supporting its use for oral mucositis in head and neck radiotherapy or high-dose chemotherapy, and discuss its potential for radiation dermatitis and lymphedema. The abstract describes these latter applications as areas where effectiveness may be possible, with suggested parameters and future research directions.
- Who or what was studied
- Patients undergoing radiotherapy for head and neck cancer or high-dose chemotherapy, and patients with cancer treatment-induced mucositis, dermatitis or lymphedema
- Limits stated in the abstract
- The abstract does not report a number of included studies and describes evidence for dermatitis and lymphedema only as possible, not established.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Photobiomodulation, Laser, Oral mucositis, Dosimetry, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.